General MedicationsORALStandard
NORLIQVA
AMLODIPINE BESYLATE
Standard Dose
EQ 1MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NORLIQVA is listed in Drugs@FDA under application 214439 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AMLODIPINE BESYLATE Form and strength SOLUTION;ORAL - EQ 1MG BASE/ML Sponsor CMP DEV LLC Submission history Latest submission status date: 2026-02-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview NORLIQVA is listed in Drugs@FDA under application 214439 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMLODIPINE BESYLATE Form and strength SOLUTION;ORAL - EQ 1MG BASE/ML Sponsor CMP DEV LLC Submission history Latest submission status date: 2026-02-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.